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Background: Studies using the multiple inert gas elimination technique (MIGET) to characterise the mechanisms of impaired gas exchange in CF,
provide conflicting results on the importance of ventilation–perfusion (VA/Q) inequality over shunt. We hypothesise that the mechanisms of gas
exchange abnormality have changed with changing CF management over the last two decades.
Methods: Detailed gas exchange was evaluated by MIGET with venous sampling in stable patients, ageN20 years, FEV1% predicted ≤50.
Results: Fifteen (14 male) subjects were studied with a mean±SD age 28.1±8.4 years, FEV1% 32.6±10.3, TLC% 111.5±12.9, PaO2 9.3±1.3 kPa,
(69.5±9.6 mmHg), and PaCO2 6.2±0.7 kPa, (45.9±5.3 mmHg). The predominant gas exchange abnormality was VA/Q inequality with a log SD of
the distributions of perfusion 0.91±0.30 and of ventilation 0.60±0.14. Unimodal distributions were seen in nine subjects, a low VA/Q mode in five
and one subject had a bimodal distribution, mean intrapulmonary shunt was negligible.
Conclusions: Subjects had a lower FEV1% by comparison with previously published studies and demonstrated severe VA/Q inequality and
negligible shunt. This suggests a low degree of complete obstruction of airways in adults with CF and severe stable pulmonary disease. The
primary mechanism of hypoxaemia in CF subjects reaching adulthood today appears to have changed with modern management over the last two
decades.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Gas exchange; MIGET1. Introduction
Cystic fibrosis (CF) is a recessively inherited condition caused
by mutation of the CF transmembrane conductance regulator
gene. Abnormalmucociliary clearance effects airway patency and
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doi:10.1016/j.jcf.2007.11.003lung destruction results in respiratory failure which is responsible
for most morbidity and mortality in adults with CF [1,2].
The primary function of the lung is to exchange gas and to
arterialise venous blood, which is achieved by bringing blood and
air very closely together so that the gases can be exchanged by
passive diffusion. There are four principle intra-pulmonary
mechanisms of hypoxia and impaired gas exchange: hypoventila-
tion, diffusion limitation, shunting and ventilation–perfusion ratio
(VA/Q) inequality. Intrapulmonary shunt occurs when blood passes
through the lung without participating in gas exchange. VA/Q
inequality occurs due to amismatch between the ventilation and the
perfusion of individual lung units and is the primary mechanism of
gas exchange impairment in both normal and diseased lungs. The
mechanisms of gas exchange impairment in CF appears to be
principally due to VA/Q inequality and shunt [3,4].d by Elsevier B.V. All rights reserved.
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nation technique (MIGET) as a means to examine detailed gas
exchange [5]. Inert gases have linear blood dissociation char-
acteristics and in a steady state, the amount of any gas
exchanged between the pulmonary capillary blood and the
alveoli is equal to the amount exchanged between the alveoli
and the atmosphere. Under these conditions, within each VA/Q
unit the quantitative exchange of any inert gas depends only on
the VA/Q ratio of the unit and the blood: gas partition coefficient
of that gas. In MIGET the simultaneous measurement of mul-
tiple inert gases with a wide range of solubilities in blood and
expired air by gas chromatography allows the derivation of a
continuous distribution of ventilation–perfusion ratios by which
to describe VA/Q inequality. The resolution of the technique is
sufficient to allow the recovery of a range of ventilation–per-
fusion ratios, spanning from 0 (shunt), to “acetone” dead space
(VA/Q ratios N100), with 48 equally spaced compartments from
0.05 to 100.0 in between these two extremes. The mathematical
basis for this technique and subsequent treatment of the data has
been fully described and validated [6]. The results from a
MIGET study are most commonly expressed by the standard
deviation of the distributions of ventilation (log SDV) and blood
flow (log SDQ) about their mean on a logarithmic scale. The
narrower the distribution and smaller the logarithmic standard
deviation the smaller the VA/Q inequality. MIGET data is also
expressed graphically with ventilation and blood flow on the y-
axis, against a logarithmic scale for VA/Q ratios on the x-axis.
The x-axis ranges between 0.005 and 100.0 for 48 compart-
ments with inserted values on a broken x-axis at each extreme;
with a VA/Q ratio of 0 for shunt and infinity for dead space.
The extent of VA/Q inequality and shunt are influenced by
airway patency and their determination is of considerable interest
in understanding the mechanisms contributing to lung disease in
CF. Despite this the detailed mechanisms of gas exchange
abnormality in CF have received only modest attention. Anato-
mical bronchopulmonary shunts were reported in early post-
mortem specimens [7]. In the 1960s eight children with CF were
examined for the presence of bronchopulmonary shunts. Right-
to-left shunts were seen in seven subjects and left-to-right shunts
at the precapillary level in five [8]. Only two studies of gas
exchange in CF have utilised theMIGET. The data from over two
decades ago, in 1982, manifested primarily shunt [3]. Whereas
data from 1999, reflecting the overall advances in the manage-
ment of CF, manifested primarily VA/Q inequality [4].
We aimed to describe the predominant mechanisms of gas
exchange impairment in stable adults with severe CF lung disease
whose management since diagnosis had reflected advances in
antibiotics, airway clearance techniques including mucolytics
with emphasis on exercise and nutrition. We wished to determine
whether shunt becomes the predominant mechanism as disease
severity increases or whether gas exchange abnormalities in those
reaching adulthood today differ from those reaching adulthood in
the 1980s. We hypothesised that the mechanism of gas exchange
abnormality in stable CF with severe lung disease would be VA/Q
inequality rather than shunting indicating a fundamental change
in the pattern of lung disease now seen in adults with severe lung
disease as compared with subjects from two decades ago.2. Materials and methods
2.1. Subjects
Stable patients over 18 years of age with CF, attending a
Sydney CF Centre, who met the inclusion criteria were invited to
participate. Subjects had a CF diagnosis based on clinical
phenotype, a positive sweat test and in the majority a confirmed
CF genotype. Inclusion criteria were the presence of severe
respiratory disease as determined by a FEV1 percent predicted
(FEV1%)≤50 and a stable disease state. Stabilitywas defined as a
FEV1%within 10%of the previous 6monthmaximum, noweight
loss or fever and the subject reporting no subjective change in
their cough frequency, sputum volume and/or discolouration and
no worsening dyspnoea. Exclusion criteria included pregnancy,
infection with Burkholderia cepacia and a clinical exacerbation.
The study protocol was approved by the Central Sydney Area
Health Service Ethics Committee (X99-0014) and informed
written consent was obtained from each patient.
2.2. Study protocol
All studies were undertaken in the morning when the subject
under study rested in a semi-recumbent position with the upper
torso at 45° to reach steady state for the MIGET. On completion
of the MIGET study arterial blood gases (ABG) were taken with
the subject in the same position. Venous cannulae were then
removed and the subject allowed to ambulate for lung volume
and gas transfer measures prior to forced expiratorymanoeuvres.
2.3. Multiple inert gas elimination technique (MIGET)
The distributions of ventilation–perfusion ratios were
measured using a modified MIGET in which expired inert gas
levels were measured and arterial levels were estimated from
peripheral venous samples from the hand 90 min following the
commencement of the inert gas infusion [9]. The protocol
involved studying subjects in a semi-recumbent position with
their upper torso at 45°. A peripheral venous cannula was in-
serted into a forearm vein and the infusion containing six inert
gases of differing solubilities was commenced. Ninety minutes
were allowed for inert gas equilibration between arterial, tissue
and venous inert gas concentrations. The patients were en-
couraged to quietly read during this time andwere not able to eat,
sleep or change position. After 80 min a second venous cannula
was inserted into the vein of the contralateral forearm which was
to be used for the collection of venous blood samples.
After 90 min, in a semi-recumbent posture, the subject
commenced breathing through a standard mouth piece attached
to a one-way valve (Model 2700, Hans Rudolph Instruments,
Kansas City, MO, USA) whilst wearing a nose-clip. The
inspiratory limb of the one-way valve was open to air, with the
expiratory flow directed via heated copper tubing into a 15 L
heated mixing box. The mixing box and tubing temperature was
maintained at 40 °C to prevent water condensation within the
collecting system. Expired gas passed from the mixing box
through a calibrated volumeter (Drager, Lubeck, Germany) and
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ventilation. When the expired minute ventilation was in a steady
state (as defined as VE within +10% of the previous five 1-
minute readings), timed samples of venous and mixed expired
gas were commenced. Three 15 ml samples of venous blood
were collected. For each venous sample duplicate samples of
mixed expired gas were collected.
Inert gas samples were analysed by gas chromatography
(Hewlett Packard models 5710A Waltham, MA and HP6890
Folsom, CA, USA). Retention and excretion ratios were
computed and the solubility of each inert gas was determined
for each individual as described [5,6]. The VA/Q distribution
was then calculated. The application of the MIGET in our
laboratory has been fully described [10].
2.4. Arterial blood gases
Arterial blood gases were taken from the radial artery at the
wrist in a standardised semi-recumbent position, with the trunk
at 45° inclination, following a local anaesthetic (1% lignocaine)
as required. PaO2, PaCO2 and pHweremeasured with electrodes
maintained at 37 °C using a radiometer electrode system
(ABL™ system 625/620, Radiometer Medical A/S, Denmark).
2.5. Lung function
Lung volumes were first measured by body plethysmography
(Gould 2800; Gould Electronics, Dayton, OH) and results were
comparedwith normal predicted values [11]. Themeasurement of
the single breath test for the diffusing capacity of carbon
monoxide (DLCO) has limitations in CF [12] andwas determined
using themethod ofOgilvie [13]. Spirometrywas then performed.
The forced expiratory volume in one second (FEV1) and forced
vital capacity (FVC) were recorded using dry-wedge spirometers
(Vitalograph S-model; Vitalograph Ltd., Buckingham UK) andTable 1
Anthropomorphic data and lung function
Subject Age Weight Height BMI FEV1% FV
%
years kg cm kgm−2
1 31 53.1 169 18.6 33.3 51
2 21 47.0 174 15.5 25.5 52
3 19 58.0 168 20.7 50.9 70
4 22 47.2 156 19.4 38.5 61
5 24 74.9 177 23.9 35.6 50
6 24 68.3 171 23.3 50.4 67
7 24 50.0 166 18.1 36.9 58
8 37 69.5 171 23.8 39.4 69
9 19 53.8 168 19.0 16.7 22
10 30 59.0 173 19.7 32.3 61
11 49 72.0 174 23.8 35.9 57
12 38 58.2 171 19.9 17.7 44
13 22 57.4 177 18.3 29.0 42
14 30 63.0 173 21.0 24.0 56
15 32 66.0 180 20.4 23.0 53
Mean 28.1 59.8 171.2 20.4 32.6 54
SD 8.4 8.9 5.7 2.5 10.3 12
Lung function data all expressed as percent predicted.values compared with normal predicted values [14]. FEV1 values
reproducible to 5% and forced exhalation for a minimum of 6 s
but for as long as the subject could comfortably manage were
required of all subjects. Inspiratory muscle pressure at residual
volume (Pimax) and expiratory muscle pressure at total lung
capacity (Pemax) were recorded with a hand held pressure gauge
and the results compared with normal predicted values [15].
2.6. Data analysis
Anthropomorphic, spirometric, lung volumes, ABG and
MIGET data were expressed as mean±standard deviation.
Correlations between the MIGET derived measures of VA/Q
dispersion, log SDQ and log SDV and the other measured
parameters were estimated by Spearman's correlation coefficient,
with 95% confidence intervals, for non-parametric parameters.
The statistical and graphical package used was GraphPad Prism
version 4.00, GraphPad software, San Diego, Cal. US.
3. Results
Fifteen subjects (14 males) consented and were enrolled with
a mean±SD age of 28.1±8.4 years and a body mass index
(BMI) of 20.4±2.5. All patients were sputum producers with a
minimum of 30 ml wet volume sputum per day, colonised with
Pseudomonas aeruginosa and were receiving pancreatic
supplementation and fat-soluble vitamins.
3.1. Lung function
The subjects had severe airflow obstruction with a mean±SD
FEV1 percent predicted (FEV1%) of 32.6±10.3 and FVC
percent predicted (FVC%) of 54.6±12.2. The subjects showed
severe gas trapping with a residual volume percent predicted
(RV%) of 233.8±61.8 and hyperinflation as measured by FRCC TLC
%
RV
%
FRC
%
Pinsp
%
Pexp
%
DLCO
%
.6 112.1 241.6 116.5 77.1 27.2 50
.2 85.0 194.7 93.5 132.5 118.0 61
.5 115.0 242.4 139.8 93.4 76.7 70
.2 107.3 251.8 131.3 115.0 90.0 65
.9 91.1 186.8 118.1 108.5 98.1 77
.1 101.6 168.6 99.7 150.0 101.0 74
.4 117.5 252.3 147.1 139.3 110.8 78
.9 126.6 207.9 138.7 174.0 75.0 67
.5 105.2 276.2 124.4 125.0 101.0 57
.5 116.5 205.3 124.4 108.0 82.0 61
.6 118.8 183.3 131.6 81.0 103.0 71
.2 109.0 306.0 – – 68.0 45
.0 58.0 120.0 103.0 94.0 81.0 40
.0 128.0 325.0 173.0 77.0 58.0 56
.0 127.0 345.0 161.0 84.0 141.0 70
.6 107.9 233.8 128.7 111.4 88.7 62.9
.2 18.6 61.8 22.6 29.8 27.1 11.5
Fig. 1. a— Subject 11 demonstrated a ventilation–perfusion distribution that was representative of the whole group (log SDQ=0.97 and log SDV=0.64). b— Subject 12 demonstrated a unimodal ventilation–perfusion
distribution with a narrow distribution (log SDQ=0.50 and log SDV=0.34). c— Subject 3 was one of two subjects which demonstrated a broad ventilation–perfusion distribution with a very small low VA/Qmode (log
SDQ=1.47 and log SDV=0.76). d— Subject 15 demonstrated the largest low VA/Q mode seen (log SDQ=1.38 and log SDV=0.62). e— Subject 10 demonstrated a bimodal ventilation–perfusion distribution (log
SDQ=1.09 and log SDV=0.93).
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mildly to moderately impaired as measured by a DLCO percent
predicted (DLCO%) of 62.9±11.5. Inspiratory and expiratory
muscle pressures were in the normal range (Table 1).
3.2. Gas exchange
The subjects were hypoxaemic at rest with a mean±SD PaO2
of 69.5±9.6 mm Hg and a PaCO2 of 45.9±5.3 mm Hg. The
assumptions on which MIGET are based require a stable state
and that the fit of the derived VA/Q distributions to the measured
data expressed as the remaining sum of squares (RSS), should
not exceed 6.0 in N50% of measurements. The mean RSS from
all data in this study was 2.6 (range 0.55 to 8.93).
The distribution of ventilation and perfusion was unimodal in
nine subjects, two subjects had a very small additional low VA/Q
mode, three subjects had a small low VA/Q mode and one had a
bimodal distribution, (Fig. 1). The mean log SDQ of 0.91±0.30
and log SDV of 0.60±0.14 show a marked broadening of
perfusion distributions. Only three of fifteen subjects had a log
SDQ less than the upper limit of normal, which is 0.56 by this
technique [16]. Moreover, in a group of this age log SDQ would
be anticipated to be approximately 0.40 and no subject was in
this range [17]. Intrapulmonary shunt was negligible with a
mean shunt of 0.5±0.7% of total cardiac output. Even if the
assumed cardiac output of 5 L was doubled the percentage shunt
remains an insignificant cause of gas exchange abnormality
(Table 2).
3.3. Correlation between MIGET and other measures
There was no significant correlation found between MIGET
derived values for log SDQ or log SDV and the anthro-
pomorphic, spirometric, lung volumes and ABG variables usingTable 2
Arterial blood gas tensions and MIGET derived data
Subject PaCO2 PaO2 Log
SDQ
Log
SDV
Shunt
kPa (mm Hg) kPa (mm Hg) %CO
1 7.5 7.1 0.90 0.58 0.0
2 6.5 10.3 0.74 0.57 0.0
3 6.0 9.1 1.47 0.76 0.5
4 4.7 10.4 0.92 0.70 0.5
5 7.1 7.3 0.80 0.51 0.0
6 6.4 9.3 0.77 0.56 0.0
7 5.5 9.7 0.53 0.65 0.3
8 5.7 8.7 1.07 0.63 0.0
9 5.7 8.8 0.41 0.40 0.9
10 5.5 12.1 1.09 0.93 0.0
11 5.6 10.8 0.97 0.64 0.2
12 6.7 9.3 0.50 0.34 0.8
13 6.1 9.2 0.92 0.46 2.8
14 6.5 8.5 1.15 0.67 0.8
15 6.4 8.5 1.38 0.62 0.7
Mean 6.2 (45.9) 9.3 (69.5) 0.91 0.60 0.5
SD 0.7 (5.3) 1.3 (9.6) 0.30 0.14 0.7
UM=Unimodal distribution, UM⁎=Unimodal distribution with very small low VA/Q
distribution. %CO=percentage of cardiac output.Spearman's r with a 95% confidence interval. The correlations
between log SDQ and log SDV and the parameters: age, BMI,
FEV1%, FVC%, TLC%, DLCO%, PaO2, PaCO2, the calculated
AaDO2 gradient or MIGET derived values of alveolar ven-
tilation were determined and were not significant (pb0.05).
4. Discussion
This study demonstrates the relative importance of ventila-
tion–perfusion inequality over shunt as the predominant mech-
anism of impaired gas exchange, in stable adult CF subjects with
moderate-to-severe lung disease.We attempted to recruit subjects
with more severe lung disease than reported in the previous
studies that measured gas exchange with MIGET. Our subjects
had a mean FEV1% of 32.6 (range: 17–51%). The highest
FEV1% in our subjects was lower than the mean of either prior
study. We used this approach to ascertain whether shunt becomes
the predominant mechanism of gas exchange impairment with
increasing severity of CF lung disease, or alternatively, whether
subjects with CF reaching adulthood today, may have different
gas exchange characteristics from subjects in the 1980s. The
results of this study are compared with the prior studies of
detailed gas exchange [3,4] in Table 3.
Dantzker studied 6 subjects using MIGET with arterial
sampling over two decades ago in 1982 and found that all had
significant intrapulmonary shunt. The mean±SD shunt as a
percentage of cardiac output was 13.6±6.7 (range: 6.7–25.5% of
the measured cardiac output). In two of the six patients the entire
calculated venous admixture resulted from themeasured shunt and
the remainder of the blood flow was distributed to a narrow and
normal range of VA/Q with a log SDQ of 0.36 and 0.29
respectively. In three patients perfusion of lung units with low
VA/Q and abnormal log SDQ made up a substantial proportion of
the venous admixture. These patients had the smallest shunts, e.g. aMode Total Ventilation Alveolar Ventilation Dead Space
L
UM⁎⁎ 11.0 4.5 6.5
UM⁎⁎ 5.5 3.8 1.7
UM⁎ 10.4 5.7 4.7
UM 8.8 5.9 2.9
UM 13.0 6.9 6.0
UM 10.1 5.6 4.5
UM 8.3 5.3 3.0
UM 13.3 7.0 6.3
UM 8.9 6.2 2.8
BiM 8.4 5.5 2.8
UM 10.8 6.1 4.7
UM 8.2 5.3 2.9
UM⁎ 11.1 6.1 5.0
UM 8.0 4.7 3.3
UM⁎⁎ 8.4 6.2 2.2
9.6 5.7 4.0
2.0 0.9 1.5
mode. UM⁎⁎=Unimodal distribution with a low VA/Q mode. BiM=Bimodal
Table 3
A comparison table summarising the results of all the studies using MIGET in CF
Study Subject
status
Number Age Weight BMI FEV1 FVC TLC RV FRC DLCO
years kg kgm−2 %pred %pred %pred %pred %pred %pred
Dantzker Stable 6 24.3 ± 5.3
(ra 17–30)
54.7±13.8 18.6±2.8 52.5±6.0
(ra 42–58)
56.1±24.0 109.8±10.7 287.9±67.9 158.1±22.1 61.7±29.2
Lagerstrand Exacerbation 10 26
(ra 17–32)
61.3±8.3 b 53
(ra 40–67)
72a 99.8 182.0 121.0 78.0
Post
treatment
10 As above As above b b b b b b b
Soni Stable 15 28.1±8.4
(ra 19–49)
59.8±8.9 20.4±2.5 32.6±10.3
(ra 17–51)
54.6±12.2 107.9±18.6 233.8±61.8 128.7±22.6 62.9±11.5
Subject PaCO2 PaO2 Log
SDQ
Log
SDV
Shunt Total Ventilation Alveolar Ventilation Dead Space
kPa (mm Hg) kPa (mm Hg) %CO L
Dantzker 5.3±9.1 (39.5±6.8) 8.8±1.8 (66.3±13.7) 0.6±0.2 b 13.6±6.7 9.3±4.5 b b
Lagerstrand 5.2±0.4 (39.0±3.0) 10.2±1.0 (76.5±7.5) 0.7±0.2 0.8±0.3 1.4±0.4 9.3±3.0 b b
5.4±0.4 (40.5±3.0) 10.7±9.1 (80.3±6.8) 0.7±0.2 0.8±0.3 0.9±0.3 9.5±2.4 b b
Soni 6.1±0.7 (45.9±5.3) 9.3±7.1 (69.5±5.3) 0.9±0.3 0.6±0.1 0.5±0.7 9.6±2.0 5.7±0.9 4.0±1.5
Study values are shown as mean (standard deviation) unless otherwise indicated.
ra= range, a=VC not FVC, b=data not derivable from published work, %CO=percentage of cardiac output.
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intrapulmonary shunts in these six patients was consistent with the
earlier non-MIGET studies of gas exchange in CF [7,8].
Lagerstrand (1999) studied ten patients (4 males) using
MIGET and venous sampling with infective exacerbations prior
to and after 2 weeks of intravenous antibiotic therapy (Tob-
ramycin and a beta lactam) and twice daily physiotherapy. All
distributionswere unimodal except for a very small additional low
VA/Q mode in one patient which consisted of 0.5% of cardiac
output. Eight perfusion distributions were broad, one with a
deviation towards low VA/Q and two with a deviation towards
high VA/Q. Two patients had bimodal ventilation distributions
with an additional mode at high VA/Q. The mean log SDQ was
0.72±0.16, the upper 95% confidence interval is 0.56 in normal
volunteerswhen using peripheral venous sampling [8]. In a young
person with normal lungs a mean value of 0.4 would be
anticipated [9]. Lagerstrand demonstrated perfusion to areas of
low VA/Q in two patients and the extent was low with 0.5 and
0.3% of the cardiac output in these two patients. Intravenous
antibiotics and intensive physiotherapy resulted in clinical
improvement and a small but significant overall improvement
in log SDQ which decreased from 0.77 to 0.66.
In Dantzker's study the predominant finding was of large
intrapulmonary shunt. The patients were described as stable, but
the details of this definition were not given. Lagerstrand studied
subjects during an exacerbation and as a group they had better
nutrition as determined byweight, with less gas trapping andwere
less hypoxic, but had similar spirometry with a mean FEV1% of
53 compared to Dantzker's group of 52.5. Lagerstrand's group
studied with venous sampling did not demonstrate significant
levels of shunting. MIGET with venous sampling has been
compared with arterial sampling and is sensitive at detecting the
presence of shunt but does not allow for exact quantification of the
size of the shunt were the cardiac output is assumed [9]. The
sensitivity of this technique allows confidence in the data obtained
by both Lagerstrand's group and our own which show negligibleshunt. Lagerstrand hypothesised that by comparison with
Dantzker's [3] study, subjects today are benefiting from better
maintenance treatments which include more frequent courses of
broad-spectrum antibiotics and new mucolytic therapies, which
influence mucus plugging, atelectasis and airway patency.
Early pathological studies [5], measures of shunt by cardiac
catheterisation [6] and the MIGET study of Dantzker
concluded that subjects with moderate-to-severe respiratory
disease invariably had regions of complete airway occlusion
and this is a plausible explanation for significant shunt. Lager-
strand suggested that the absence of significant shunt and
relatively low estimated levels of areas of low VA/Q would
indicate that complete obstruction of airways by mucus af-
fecting significant parts of the lungs was unusual in his
subjects. An alternate and possibly more likely explanation is
that lung units distal to completely obstructed airways are to a
varying degree receiving collateral ventilation. Collateral
ventilation channels (the canals of Lambert, channels of
Martin and pores of Kohn) are of increasing relative im-
portance when there is partial or complete airway obstruction
[18]. This may in part explain the absence of significant shunt
or areas of low VA/Q in a patient group in whom these may
have been expected.
Since Dantzker's pioneering study, the median survival for CF
in the US has improved from 18 years to 35.1 years in 2004 [19].
This generational change reflects to a differing extent, the overall
advances in routine clinical management with respect to anti-
biotics, airway clearance techniques and the use of mucolytics,
exercise and emphasis on nutrition, together with the use of
oxygen and NIV for severe respiratory disease. Lagerstrand
suggested that the patients in the Dantzker group who did not have
these treatment regimensmay have hadmoremucus pluggingwith
atelectasis and hence shunt. Mucus plugging explains Dantzker's
findings, however, the anatomical shunts found in earlier post-
mortem specimens [5] and bronchopulmonary shunts seen in the
1960s [6], suggest more permanent structural changes. It was also
291R. Soni et al. / Journal of Cystic Fibrosis 7 (2008) 285–291suggested that a cause for shunting in the earlier study related to
more severe lung disease. We attempted to avoid this concern by
selecting subjects with lower FEV1. The subjects finally enrolled
had a lower FEV1 and higher PaCO2 but more favourable PaO2.
The differences in technical measurement of spirometric variables,
RV, RV/TLC and FRC between the time of Dantzker's study and
our own preclude a definitive comparison of severity of small
airway disease and hyperinflation. We hypothesise that the
management received from infancy while the lung is still develop-
ing its normal bronchial architecture might ameliorate structural
damage. Our current patients born in the 1980swho have survived
into adulthood with end-stage pulmonary disease may therefore
have a different anatomy, and relative absence of anatomical
shunts, with different gas exchange abnormalities compared with
those of previous generations. It is suggested that the examination
of the native lungs of patients' with CF having lung transplantation
might shed light on this hypothesis.
We have demonstrated that VA/Q inequality is reflected by an
elevated log SDQ and a shift of perfusion to areas of low VA/Q.
As in prior MIGET studies there was no significant correlation
between log SDQ and spirometry. MIGET studies in acute
asthma have shown that when there is a dissociation between
changes in spirometry and gas exchange measures derived by
MIGET, then the changes in the log SDQ are the reflection of
changes in small airways [20]. This information points to the site
within the respiratory tract where the pathophysiology of gas
exchange impairment occurs. Changes in small airway patency
will affect the distribution of ventilation to lung units of low
VA/Q and hence have a primary effect on log SDQ. The lack of
correlation between log SDQ and the calculated AaDO2 gradient
is not surprising due to the influence of extrapulmonary factors
(e.g. cardiac output and minute ventilation) on the later.
We conclude that the primary mechanism of hypoxaemia in
stable CF patients with severe pulmonary disease relates to VA/Q
inequality rather than shunting. Current maintenance therapy
may by limiting mucus plugging or in the long-term by pre-
venting the development of anatomical shunts, account for the
absence of significant intrapulmonary shunt in this group.
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